Metraipolis › archive › dc_b89d0a6cf910

Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis — Europe PMC PMID:42332777

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42332777
DOI
10.1186/s42358-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-19T06:38:05.466Z
SHA-256 of the archived text
6b854ced3280eb7525d0056e25773d572aa7c9be1a27c9f23677e85a3ef7d7ec
Stable URL of this page
https://metraipolis.com/documento/dc_b89d0a6cf910

How to cite

Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis — Europe PMC PMID:42332777 — Europe PMC (en), https://europepmc.org/article/MED/42332777 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b89d0a6cf910 (Metraipolis archive dc_b89d0a6cf910, sha256 6b854ced3280eb7525d0056e25773d572aa7c9be1a27c9f23677e85a3ef7d7ec)
BibTeX
@misc{dcb89d0a6cf910,
  title = {Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis — Europe PMC PMID:42332777},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42332777},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b89d0a6cf910; sha256 6b854ced3280eb7525d0056e25773d572aa7c9be1a27c9f23677e85a3ef7d7ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42332777. Agents can read the archived copy with the MCP tool read_document.